Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries.

ABSTRACT:

Background

Smokeless tobacco (ST) is consumed by more than 300 million people worldwide. The distribution, determinants and health risks of ST differ from that of smoking; hence, there is a need to highlight its distinct health impact. We present the latest estimates of the global burden of disease due to ST use.

Methods

The ST-related disease burden was estimated for all countries reporting its use among adults. Using systematic searches, we first identified country-specific prevalence of ST use in men and women. We then revised our previously published disease risk estimates for oral, pharyngeal and oesophageal cancers and cardiovascular diseases by updating our systematic reviews and meta-analyses of observational studies. The updated country-specific prevalence of ST and

SUBMITTER: Siddiqi K 

PROVIDER: S-EPMC7422596 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature